OBJECTIVES: To assess subjectively perceived, real-world benefits longitudinally for unilateral cochlear implant (CI) recipients in a multinational population treated routinely. To identify possible predictors of self-reported benefits. DESIGN: This was a prospective, multicenter, repeated-measures study. Self-assessment of performance at preimplantation and postimplantation at 1, 2, and 3 years using standardized, validated, local language versions of the Speech, Spatial, and Qualities of Hearing Scale (SSQ), and the Health Utilities Index Mark 3 (HUI3) was performed. Outcomes were analyzed using a longitudinal mixed-effects model incorporating country effect. Patient demographics were explored for associations with change over time. SUBJECTS: Two hundred ninety-one routinely treated, unilateral CI recipients, aged 13-81 years, from 9 clinics across 4 countries. RESULTS: Highly significant improvements were observed for all outcome measures (p < 0.0001). Postimplantation, mean outcome scores remained stable beyond 1 year, with notable individual variability. A significant association for one or more outcomes with preimplantation contralateral hearing aid use, telephone use, age at implantation, implantation side, preimplantation comorbidities, dizziness, and tinnitus was observed (p < 0.004). CONCLUSIONS: Longitudinal benefits of CI treatment can be measured using clinically standardized self-assessment tools to provide a holistic view of patient-related benefits in routine clinical practice for aggregated data from multinational populations. Self-reported outcomes can provide medical-based evidence regarding CI treatment to support decision-making by health service providers.
OBJECTIVES: To assess subjectively perceived, real-world benefits longitudinally for unilateral cochlear implant (CI) recipients in a multinational population treated routinely. To identify possible predictors of self-reported benefits. DESIGN: This was a prospective, multicenter, repeated-measures study. Self-assessment of performance at preimplantation and postimplantation at 1, 2, and 3 years using standardized, validated, local language versions of the Speech, Spatial, and Qualities of Hearing Scale (SSQ), and the Health Utilities Index Mark 3 (HUI3) was performed. Outcomes were analyzed using a longitudinal mixed-effects model incorporating country effect. Patient demographics were explored for associations with change over time. SUBJECTS: Two hundred ninety-one routinely treated, unilateral CI recipients, aged 13-81 years, from 9 clinics across 4 countries. RESULTS: Highly significant improvements were observed for all outcome measures (p < 0.0001). Postimplantation, mean outcome scores remained stable beyond 1 year, with notable individual variability. A significant association for one or more outcomes with preimplantation contralateral hearing aid use, telephone use, age at implantation, implantation side, preimplantation comorbidities, dizziness, and tinnitus was observed (p < 0.004). CONCLUSIONS: Longitudinal benefits of CI treatment can be measured using clinically standardized self-assessment tools to provide a holistic view of patient-related benefits in routine clinical practice for aggregated data from multinational populations. Self-reported outcomes can provide medical-based evidence regarding CI treatment to support decision-making by health service providers.
Keywords:
Health Utilities Index Mark 3; Health utility; Hearing benefits; Hearing outcomes; Observational study; Patient registry; Patient-related benefits; Quality of life; Speech, Spatial, and Qualities of Hearing Scale
Authors: Godelieve W J A Damen; Andy J Beynon; Paul F M Krabbe; Jef J S Mulder; Emmanuel A M Mylanus Journal: Otolaryngol Head Neck Surg Date: 2007-04 Impact factor: 3.497
Authors: David Feeny; William Furlong; George W Torrance; Charles H Goldsmith; Zenglong Zhu; Sonja DePauw; Margaret Denton; Michael Boyle Journal: Med Care Date: 2002-02 Impact factor: 2.983
Authors: M Marx; I Mosnier; J Belmin; J Wyss; C Coudert-Koall; A Ramos; R Manrique Huarte; R Khnifes; O Hilly; A Martini; D Cuda Journal: BMC Geriatr Date: 2020-07-23 Impact factor: 3.921
Authors: Chris J James; Petra L Graham; Frank A Betances Reinoso; Silvia N Breuning; Marcin Durko; Alicia Huarte Irujo; Juan Royo López; Lida Müller; Adam Perenyi; Rafael Jaramillo Saffon; Sandra Salinas Garcia; Mark Schüssler; Margarita J Schwarz Langer; Piotr H Skarzynski; Dianne J Mecklenburg Journal: Front Aging Neurosci Date: 2021-02-25 Impact factor: 5.750
Authors: Elke M J Devocht; A Miranda L Janssen; Josef Chalupper; Robert J Stokroos; Herman Kingma; Erwin L J George Journal: PLoS One Date: 2020-12-03 Impact factor: 3.240
Authors: Ellen Andries; Annick Gilles; Vedat Topsakal; Olivier Vanderveken; Paul Van de Heyning; Vincent Van Rompaey; Griet Mertens Journal: Eur Arch Otorhinolaryngol Date: 2021-03-08 Impact factor: 2.503
Authors: Christiane Völter; Lisa Götze; Stefan Dazert; Michael Falkenstein; Jan Peter Thomas Journal: Clin Interv Aging Date: 2018-04-20 Impact factor: 4.458